| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179021A1 Human gaba b receptor 1 promoters |
| 02/13/2002 | EP1179019A2 Immunogenic peptides derived from mage and the use thereof |
| 02/13/2002 | EP1179017A1 Expression of heparin-binding protein in recombinant mammalian cells |
| 02/13/2002 | EP1179015A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
| 02/13/2002 | EP1179014A1 Derivatives of the b or z domain from staphylococcal protein a (spa) interacting with at least one domain of human factor viii |
| 02/13/2002 | EP1179013A1 Protein scaffold and its use to multimerise monomeric polypeptides |
| 02/13/2002 | EP1179010A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179007A1 Self-assembling biomolecular structures |
| 02/13/2002 | EP1179003A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene |
| 02/13/2002 | EP1179002A1 Methods using mechanisms of action of aroa |
| 02/13/2002 | EP1178999A2 L-ribo-lna analogues |
| 02/13/2002 | EP1178836A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 02/13/2002 | EP1178835A1 Compositions and methods for improving learning and memory |
| 02/13/2002 | EP1178829A1 Human monoclonal antibody |
| 02/13/2002 | EP1178828A1 Death domain containing receptor 4 |
| 02/13/2002 | EP1178822A2 New vaccine formulations - 2 |
| 02/13/2002 | EP1178815A1 Death domain containing receptors |
| 02/13/2002 | EP1178785A1 Compositions and methods for identifying antigens which elicit an immune response |
| 02/13/2002 | EP1178722A1 eNOS MUTATIONS USEFUL FOR GENE THERAPY AND THERAPEUTIC SCREENING |
| 02/13/2002 | EP1178721A2 Process of rapid variety-independent plant transformation |
| 02/13/2002 | EP1007671B1 Fanconi-gen ii |
| 02/13/2002 | EP0912759B1 Diagnostic method and apparatus for detecting a predisposition to certain disease states, especially osteoporosis, based on polymorphism in an il-6 gene |
| 02/13/2002 | EP0912470B1 Method and device for purifying and enriching molecules |
| 02/13/2002 | EP0876503B1 Process for assessing the activity of drugs |
| 02/13/2002 | EP0866878A4 Detection of mammary tumor virus-like sequences in human breast cancer |
| 02/13/2002 | EP0866876B1 Process for the preparation of recombinant proteins in e.coli by high cell density fermentation |
| 02/13/2002 | EP0842295B1 Method for nucleic acid sequencing |
| 02/13/2002 | EP0812859B1 ANTIFACTOR Xa-TISSUE FACTOR PATHWAY INHIBITOR COMPLEX MONOCLONAL ANTIBODY AND USE OF THE SAME |
| 02/13/2002 | EP0791074B1 Method for the detection of ras oncogenes, in particular the k-ras ancogene |
| 02/13/2002 | EP0791051B1 Neural cultures |
| 02/13/2002 | EP0693925B1 Production of a recombinant factor xa inhibitor of leech hirudo medicinalis |
| 02/13/2002 | CN1335893A Statistical combining of cell expression profiles |
| 02/13/2002 | CN1335892A Phytomics: A genomic-based approach to herbal compositions |
| 02/13/2002 | CN1335891A Clean synthetic vectors, plasmids, transgenic plants and plant parts containing them, and methods for obtaining them |
| 02/13/2002 | CN1335890A High efficiency mammalian gene expression vectors that contain exogenous promoter and entire 5' untranslated region in the upstream from start codon for inherent gene as transcription regulatory site |
| 02/13/2002 | CN1335889A Chimeric gene encoding the antigenic determinants of four proteins of L.INFANTUM |
| 02/13/2002 | CN1335888A OPG fusion protein compositions and methods |
| 02/13/2002 | CN1335887A Angiocidin: A Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor |
| 02/13/2002 | CN1335886A Glufosinate tolerant rice |
| 02/13/2002 | CN1335884A Interluckin 17-like receptor protein |
| 02/13/2002 | CN1335855A Novel protein, gene encoding the same and method of utilization thereof |
| 02/13/2002 | CN1335853A Alpha v beta b integrin inhibitors |
| 02/13/2002 | CN1335789A Apparatus and methods for efficient processing of biological samples on slides |
| 02/13/2002 | CN1335450A Petroleum peptide PCR-petroleum enzyme, coenzyme and its special activator |
| 02/13/2002 | CN1335403A Process for producing nucleotide by fermentation |
| 02/13/2002 | CN1335401A Process for producing matter with microbe |
| 02/13/2002 | CN1335398A Recombinant adenovirus vector capable of being duplicated and spread specifcally inside tumor cell |
| 02/13/2002 | CN1335397A Novel gene P40 containing acyl group carrying protein-like structural domain |
| 02/13/2002 | CN1335396A Novel gene 709B1, HFT02 and HFT05 inside human brain and thymus |
| 02/13/2002 | CN1335395A High-activity cellulase composition and its prepn |
| 02/13/2002 | CN1335394A Generation of L-glutamic acid bacterium and process for producing L-glutamic acid |
| 02/13/2002 | CN1079114C Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by use of these markers |
| 02/12/2002 | US6346656 Increasing resistance of plants or algal cells by genetically engineering a unicellular green alga resistant to porphyrin herbicides |
| 02/12/2002 | US6346655 Trichothecne-Resistant transgenic plants |
| 02/12/2002 | US6346614 Hybrid oligonucleotide phosphorothioates |
| 02/12/2002 | US6346613 An antisense oligonucleotide that hybridizes with a occludin mrna and disrupts tight junctions, to increase cell layer permeability to solutes and drugs |
| 02/12/2002 | US6346611 High affinity TGfβ nucleic acid ligands and inhibitors |
| 02/12/2002 | US6346608 MecB |
| 02/12/2002 | US6346607 A protein that induces apoptosis or binds cytochrome c; diagnosis and therapy for multiple sclerosis, parkinson's and alzheimer's diseases, cardiovascular diseases, strokes, toxin induced liver disease, cancer, lupus and herpes virus |
| 02/12/2002 | US6346606 A protein; diagnosis and therapy for tumor diseases, central nervous system diseases, glioblastomas, and breast cancer |
| 02/12/2002 | US6346602 Peptide mimics of the cytokine receptor common γ chain and methods and compositions for making and using the same |
| 02/12/2002 | US6346513 Internal deletion of amino acids 741 through 1668; hemophilia treatment |
| 02/12/2002 | US6346510 Antiproliferative, anticarcinogenic and antitumor agents |
| 02/12/2002 | US6346421 Adding sample to ultracentrifuge tube having distinct regions which taper to bottom of tube where inner lining is serrated, then centrifuging; for fast classification |
| 02/12/2002 | US6346416 Antisense inhibition of HPK/GCK-like kinase expression |
| 02/12/2002 | US6346415 Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors |
| 02/12/2002 | US6346414 Transposition assembly for gene transfer in eukaryotes |
| 02/12/2002 | US6346410 Motor proteins and methods for their use |
| 02/12/2002 | US6346409 Tryptophenyl tRNA synthetase from Streptococcus pneumoniae |
| 02/12/2002 | US6346407 Xylanase, microorganisms producing it, DNA molecules, methods for preparing this xylanase and uses of the latter |
| 02/12/2002 | US6346406 Elongation factor-2 kinase (EF-2 kinase), and methods of use therefor |
| 02/12/2002 | US6346405 Amino acid sequence of enzyme involved in aromatic amino acid biosynthesis; fungicides |
| 02/12/2002 | US6346403 Polynucleotides which code for methionyl-trna formyltransferase and methionyl-trna synthetase of defined amino acid sequences; for production of transgenic plants with altered methionine content; improved foods and feeds |
| 02/12/2002 | US6346399 Isolating dna subsets from two samples for genomic mismatch analysis by replicating portions of each sample twice using two different oligonucleotides containing nucleotide repeats attatched to solid support, mixing, and hybridization |
| 02/12/2002 | US6346398 Ribozyme or antisense nucleic acid which inhibits synthesis, gene expression and/or stability of messenger rna encoding the flt-1 receptor of human or mouse receptor; treatment of diabetic retinopathy; angiogenesis inhibitors |
| 02/12/2002 | US6346394 Dna having specific nucleotide sequence; for recombinant production of enzyme and high yield, industrial scale production of trehalose |
| 02/12/2002 | US6346393 Polynucleotides encoding a ribonuclease s |
| 02/12/2002 | US6346392 Amino acid sequence from streptococcus; drug screening of bactericides and bacteriostats |
| 02/12/2002 | US6346388 Method of identifying agonist and antagonists for tumor necrosis related receptors TR1 and TR2 |
| 02/12/2002 | US6346381 Determination whether nucleotides from individual have one or more pg1-related biallelic markers or mutants; medical diagnosis |
| 02/12/2002 | US6346380 Diagnosing psychiatric, psychological, and nervous system disorders; amplification, molecular hybridization; genetic engineering |
| 02/12/2002 | US6346379 Thermostable DNA polymerases incorporating nucleoside triphosphates labeled with fluorescein family dyes |
| 02/12/2002 | US6346375 NANBV diagnostics and vaccines |
| 02/12/2002 | US6346373 Whole cell assay for cathepsin K activity |
| 02/12/2002 | US6346249 Cancer treatment with antigens |
| 02/12/2002 | US6346248 Methods of treating autoimmune diseases with a CD86-specific immunotoxin |
| 02/12/2002 | US6346246 Antibodies that bind human haemopoietic maturation factor |
| 02/12/2002 | US6346244 Fungal protein disulfide isomerase |
| 02/12/2002 | US6346101 Photon-mediated introduction of biological materials into cells and/or cellular components |
| 02/12/2002 | CA2259152C Adenovirus e4 proteins for inducing cell death |
| 02/12/2002 | CA2223776C Method of treatment for lung diseases using antisense oligonucleotides |
| 02/12/2002 | CA2186018C Highly-purified recombinant reverse transcriptase |
| 02/12/2002 | CA2131837C High molecular weight surface proteins of non-typeable haemophilus |
| 02/12/2002 | CA2068204C Latency associated peptides and uses therefor |
| 02/12/2002 | CA2066491C Human neurokinin-1 receptor |
| 02/12/2002 | CA1341339C Arg-serpin human plasminogen activator inhibitor designated pai-2 |
| 02/11/2002 | CA2740282A1 Purification of hbv antigens for use in vaccines |
| 02/09/2002 | CA2354726A1 Sodium ion-driven chloride/bi-carbonate exchanger |
| 02/08/2002 | CA2353772A1 Process for producing a target fermentation product |